PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
8.91%
Some net income increase while BRZE is negative at -1.43%. John Neff would see a short-term edge over the struggling competitor.
26.47%
D&A growth well above BRZE's 9.73%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
2.70%
Less SBC growth vs. BRZE's 11.72%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
82.05%
Slight usage while BRZE is negative at -179.89%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-332.36%
Both yoy AR lines negative, with BRZE at -100.39%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-285.43%
Negative yoy inventory while BRZE is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
203.09%
A yoy AP increase while BRZE is negative at -200.36%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-4827.66%
Both reduce yoy usage, with BRZE at -297.44%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-40.65%
Negative yoy while BRZE is 55.82%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
65.15%
Some CFO growth while BRZE is negative at -46.56%. John Neff would note a short-term liquidity lead over the competitor.
-64.60%
Negative yoy CapEx while BRZE is 50.44%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5738.47%
Both yoy lines negative, with BRZE at -418.26%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-50.00%
We cut debt repayment yoy while BRZE is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-101.60%
Both yoy lines negative, with BRZE at -35.20%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.